TEVA PHARMACEUTICAL INDUSTRIES LTD - 8-K Filing

Teva issued $4.7B in new senior notes and plans to redeem over $5B in existing debt (Items: 1.01 Entry into a Material Definitive Agreement, 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off Balance Sheet Arrangement of a Registrant, 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit 4)

SEC EDGAR ·

Tickers: $TEVA

Read the full article at SEC EDGAR

More Regulatory news